nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—MAOA—bipolar disorder	0.452	0.57	CbGaD
Naratriptan—HTR1A—bipolar disorder	0.342	0.43	CbGaD
Naratriptan—MAOA—locus ceruleus—bipolar disorder	0.0119	0.22	CbGeAlD
Naratriptan—HTR1B—telencephalic ventricle—bipolar disorder	0.00768	0.142	CbGeAlD
Naratriptan—HTR1D—telencephalic ventricle—bipolar disorder	0.00744	0.137	CbGeAlD
Naratriptan—HTR1A—telencephalic ventricle—bipolar disorder	0.0062	0.114	CbGeAlD
Naratriptan—HTR1A—blood plasma—bipolar disorder	0.00295	0.0545	CbGeAlD
Naratriptan—MAOA—blood plasma—bipolar disorder	0.0027	0.0498	CbGeAlD
Naratriptan—HTR1F—nervous system—bipolar disorder	0.00266	0.049	CbGeAlD
Naratriptan—HTR1F—brain—bipolar disorder	0.00203	0.0374	CbGeAlD
Naratriptan—Almotriptan—MAOA—bipolar disorder	0.0014	0.257	CrCbGaD
Naratriptan—MAOA—adrenal cortex—bipolar disorder	0.00137	0.0253	CbGeAlD
Naratriptan—Sumatriptan—MAOA—bipolar disorder	0.00135	0.247	CrCbGaD
Naratriptan—HTR1B—nervous system—bipolar disorder	0.00109	0.0201	CbGeAlD
Naratriptan—HTR1D—nervous system—bipolar disorder	0.00105	0.0194	CbGeAlD
Naratriptan—Sumatriptan—HTR1A—bipolar disorder	0.00102	0.187	CrCbGaD
Naratriptan—MAOA—thyroid gland—bipolar disorder	0.000954	0.0176	CbGeAlD
Naratriptan—HTR1A—nervous system—bipolar disorder	0.000879	0.0162	CbGeAlD
Naratriptan—Sumatriptan—DRD2—bipolar disorder	0.000863	0.158	CrCbGaD
Naratriptan—HTR1B—brain—bipolar disorder	0.000832	0.0153	CbGeAlD
Naratriptan—HTR1A—cerebellum—bipolar disorder	0.000827	0.0152	CbGeAlD
Naratriptan—Eletriptan—HTR1A—bipolar disorder	0.000823	0.151	CrCbGaD
Naratriptan—HTR1D—brain—bipolar disorder	0.000806	0.0149	CbGeAlD
Naratriptan—MAOA—nervous system—bipolar disorder	0.000803	0.0148	CbGeAlD
Naratriptan—MAOA—cerebellum—bipolar disorder	0.000755	0.0139	CbGeAlD
Naratriptan—HTR1A—brain—bipolar disorder	0.000672	0.0124	CbGeAlD
Naratriptan—MAOA—brain—bipolar disorder	0.000614	0.0113	CbGeAlD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	7.72e-05	0.000528	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—DRD1—bipolar disorder	7.69e-05	0.000526	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2C—bipolar disorder	7.69e-05	0.000526	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—POMC—bipolar disorder	7.59e-05	0.000519	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	7.56e-05	0.000517	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—ADCY2—bipolar disorder	7.49e-05	0.000512	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—DRD3—bipolar disorder	7.45e-05	0.000509	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—DRD2—bipolar disorder	7.42e-05	0.000507	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—POMC—bipolar disorder	7.34e-05	0.000502	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—TAC1—bipolar disorder	7.29e-05	0.000498	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TRPC3—bipolar disorder	7.29e-05	0.000498	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—DRD4—bipolar disorder	7.23e-05	0.000494	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD5—bipolar disorder	7.17e-05	0.00049	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—DRD1—bipolar disorder	7.15e-05	0.000489	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2C—bipolar disorder	7.15e-05	0.000489	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TRPC3—bipolar disorder	7.13e-05	0.000488	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DGKH—bipolar disorder	7.12e-05	0.000487	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—RGS4—bipolar disorder	7.03e-05	0.000481	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL1B—bipolar disorder	7.01e-05	0.000479	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ADM—bipolar disorder	6.95e-05	0.000475	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—DRD3—bipolar disorder	6.92e-05	0.000473	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADM—bipolar disorder	6.81e-05	0.000465	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—ADCY2—bipolar disorder	6.81e-05	0.000465	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PDE4B—bipolar disorder	6.77e-05	0.000463	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TSHB—bipolar disorder	6.77e-05	0.000463	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TACR1—bipolar disorder	6.77e-05	0.000463	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—DRD2—bipolar disorder	6.74e-05	0.00046	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	6.72e-05	0.000459	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—DRD4—bipolar disorder	6.72e-05	0.000459	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NDUFV2—bipolar disorder	6.64e-05	0.000454	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TSHB—bipolar disorder	6.63e-05	0.000453	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PDE4B—bipolar disorder	6.63e-05	0.000453	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TACR1—bipolar disorder	6.63e-05	0.000453	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TRPC3—bipolar disorder	6.62e-05	0.000452	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD5—bipolar disorder	6.51e-05	0.000445	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TRPC3—bipolar disorder	6.48e-05	0.000443	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKR1C4—bipolar disorder	6.43e-05	0.00044	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—RGS4—bipolar disorder	6.39e-05	0.000437	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADM—bipolar disorder	6.31e-05	0.000432	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—DRD2—bipolar disorder	6.26e-05	0.000428	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADM—bipolar disorder	6.18e-05	0.000423	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	6.17e-05	0.000421	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PDE4B—bipolar disorder	6.15e-05	0.000421	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TACR1—bipolar disorder	6.15e-05	0.000421	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TSHB—bipolar disorder	6.15e-05	0.000421	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKR1C4—bipolar disorder	6.13e-05	0.000419	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TRPC3—bipolar disorder	6.11e-05	0.000418	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	6.04e-05	0.000413	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PDE4B—bipolar disorder	6.02e-05	0.000412	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TSHB—bipolar disorder	6.02e-05	0.000412	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TACR1—bipolar disorder	6.02e-05	0.000412	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKR1C4—bipolar disorder	6e-05	0.00041	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—bipolar disorder	5.96e-05	0.000407	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR2A—bipolar disorder	5.88e-05	0.000402	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADM—bipolar disorder	5.83e-05	0.000399	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—POMC—bipolar disorder	5.78e-05	0.000395	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NR1D1—bipolar disorder	5.78e-05	0.000395	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	5.76e-05	0.000394	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR2A—bipolar disorder	5.76e-05	0.000394	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TSHB—bipolar disorder	5.68e-05	0.000388	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PDE4B—bipolar disorder	5.68e-05	0.000388	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TACR1—bipolar disorder	5.68e-05	0.000388	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DGKH—bipolar disorder	5.64e-05	0.000386	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR1A—bipolar disorder	5.61e-05	0.000383	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NCAN—bipolar disorder	5.52e-05	0.000378	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TAC1—bipolar disorder	5.52e-05	0.000378	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DGKH—bipolar disorder	5.52e-05	0.000377	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR1A—bipolar disorder	5.49e-05	0.000375	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TRPC3—bipolar disorder	5.44e-05	0.000372	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—DRD1—bipolar disorder	5.42e-05	0.00037	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2C—bipolar disorder	5.42e-05	0.00037	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—SLC5A3—bipolar disorder	5.41e-05	0.00037	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TAC1—bipolar disorder	5.41e-05	0.00037	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2C—bipolar disorder	5.3e-05	0.000363	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—DRD1—bipolar disorder	5.3e-05	0.000363	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—DRD3—bipolar disorder	5.24e-05	0.000359	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2A—bipolar disorder	5.2e-05	0.000355	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADM—bipolar disorder	5.19e-05	0.000354	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD5—bipolar disorder	5.16e-05	0.000353	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—DRD3—bipolar disorder	5.14e-05	0.000351	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR1A—bipolar disorder	5.09e-05	0.000348	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—DRD4—bipolar disorder	5.09e-05	0.000348	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RGS4—bipolar disorder	5.06e-05	0.000346	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TSHB—bipolar disorder	5.05e-05	0.000345	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PDE4B—bipolar disorder	5.05e-05	0.000345	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TACR1—bipolar disorder	5.05e-05	0.000345	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD5—bipolar disorder	5.05e-05	0.000345	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TAC1—bipolar disorder	5.01e-05	0.000343	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR1A—bipolar disorder	4.99e-05	0.000341	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—DRD4—bipolar disorder	4.99e-05	0.000341	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RGS4—bipolar disorder	4.95e-05	0.000339	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TRPC3—bipolar disorder	4.94e-05	0.000337	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2C—bipolar disorder	4.92e-05	0.000336	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—DRD1—bipolar disorder	4.92e-05	0.000336	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TAC1—bipolar disorder	4.91e-05	0.000336	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—DRD1—bipolar disorder	4.82e-05	0.000329	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2C—bipolar disorder	4.82e-05	0.000329	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ADCY2—bipolar disorder	4.79e-05	0.000328	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—DRD3—bipolar disorder	4.76e-05	0.000326	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—DRD2—bipolar disorder	4.74e-05	0.000324	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2A—bipolar disorder	4.72e-05	0.000323	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADM—bipolar disorder	4.71e-05	0.000322	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR1A—bipolar disorder	4.7e-05	0.000322	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—POMC—bipolar disorder	4.69e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADCY2—bipolar disorder	4.69e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—DRD3—bipolar disorder	4.66e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—DRD2—bipolar disorder	4.64e-05	0.000318	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TAC1—bipolar disorder	4.63e-05	0.000317	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—DRD4—bipolar disorder	4.62e-05	0.000316	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	4.6e-05	0.000314	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—POMC—bipolar disorder	4.6e-05	0.000314	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TSHB—bipolar disorder	4.59e-05	0.000314	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PDE4B—bipolar disorder	4.59e-05	0.000314	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TACR1—bipolar disorder	4.59e-05	0.000314	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKR1C4—bipolar disorder	4.57e-05	0.000312	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DRD1—bipolar disorder	4.54e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2C—bipolar disorder	4.54e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—DRD4—bipolar disorder	4.53e-05	0.00031	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NTRK2—bipolar disorder	4.42e-05	0.000302	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DRD3—bipolar disorder	4.4e-05	0.000301	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2A—bipolar disorder	4.38e-05	0.0003	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GSK3A—bipolar disorder	4.38e-05	0.000299	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADCY2—bipolar disorder	4.35e-05	0.000298	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—DRD2—bipolar disorder	4.31e-05	0.000294	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DRD4—bipolar disorder	4.27e-05	0.000292	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADCY2—bipolar disorder	4.26e-05	0.000291	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—DRD2—bipolar disorder	4.22e-05	0.000288	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DGKH—bipolar disorder	4.21e-05	0.000288	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—POMC—bipolar disorder	4.15e-05	0.000284	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TAC1—bipolar disorder	4.12e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD1—bipolar disorder	4.04e-05	0.000276	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2C—bipolar disorder	4.04e-05	0.000276	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADCY2—bipolar disorder	4.02e-05	0.000275	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TCF7L2—bipolar disorder	4.01e-05	0.000274	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—DRD2—bipolar disorder	3.98e-05	0.000272	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CLOCK—bipolar disorder	3.91e-05	0.000268	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD3—bipolar disorder	3.91e-05	0.000267	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TRPC3—bipolar disorder	3.91e-05	0.000267	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD5—bipolar disorder	3.85e-05	0.000263	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TRPC3—bipolar disorder	3.83e-05	0.000262	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TPH2—bipolar disorder	3.81e-05	0.000261	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CACNB2—bipolar disorder	3.81e-05	0.000261	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TSHB—bipolar disorder	3.81e-05	0.000261	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD4—bipolar disorder	3.8e-05	0.00026	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RGS4—bipolar disorder	3.77e-05	0.000258	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—POMC—bipolar disorder	3.77e-05	0.000258	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—DPYD—bipolar disorder	3.75e-05	0.000256	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TAC1—bipolar disorder	3.74e-05	0.000256	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADM—bipolar disorder	3.73e-05	0.000255	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD1—bipolar disorder	3.67e-05	0.000251	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2C—bipolar disorder	3.67e-05	0.000251	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADM—bipolar disorder	3.65e-05	0.00025	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PDE4B—bipolar disorder	3.63e-05	0.000248	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TSHB—bipolar disorder	3.63e-05	0.000248	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TACR1—bipolar disorder	3.63e-05	0.000248	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NTRK1—bipolar disorder	3.6e-05	0.000246	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADCY2—bipolar disorder	3.58e-05	0.000244	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TACR1—bipolar disorder	3.56e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TSHB—bipolar disorder	3.56e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PDE4B—bipolar disorder	3.56e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD3—bipolar disorder	3.55e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD2—bipolar disorder	3.54e-05	0.000242	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—S100B—bipolar disorder	3.5e-05	0.000239	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—POMC—bipolar disorder	3.5e-05	0.000239	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CACNA1C—bipolar disorder	3.49e-05	0.000238	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD4—bipolar disorder	3.45e-05	0.000236	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3C2A—bipolar disorder	3.4e-05	0.000232	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2A—bipolar disorder	3.32e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2A—bipolar disorder	3.25e-05	0.000222	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADCY2—bipolar disorder	3.25e-05	0.000222	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD2—bipolar disorder	3.21e-05	0.00022	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NRG1—bipolar disorder	3.09e-05	0.000211	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—SNAP25—bipolar disorder	3.05e-05	0.000208	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2A—bipolar disorder	3.02e-05	0.000206	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR1A—bipolar disorder	3.01e-05	0.000206	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TAC1—bipolar disorder	2.96e-05	0.000203	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2A—bipolar disorder	2.95e-05	0.000202	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR1A—bipolar disorder	2.95e-05	0.000201	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TRPC3—bipolar disorder	2.92e-05	0.000199	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD1—bipolar disorder	2.91e-05	0.000199	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2C—bipolar disorder	2.91e-05	0.000199	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TAC1—bipolar disorder	2.9e-05	0.000198	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD1—bipolar disorder	2.84e-05	0.000194	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2C—bipolar disorder	2.84e-05	0.000194	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NTRK2—bipolar disorder	2.83e-05	0.000193	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD3—bipolar disorder	2.81e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GSK3A—bipolar disorder	2.8e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2A—bipolar disorder	2.79e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADM—bipolar disorder	2.78e-05	0.00019	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NTRK2—bipolar disorder	2.77e-05	0.000189	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD3—bipolar disorder	2.76e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GSK3A—bipolar disorder	2.74e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD4—bipolar disorder	2.73e-05	0.000187	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TSHB—bipolar disorder	2.71e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDE4B—bipolar disorder	2.71e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TACR1—bipolar disorder	2.71e-05	0.000185	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADCY2—bipolar disorder	2.7e-05	0.000184	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD4—bipolar disorder	2.67e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—POMC—bipolar disorder	2.65e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—POMC—bipolar disorder	2.6e-05	0.000178	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADCY2—bipolar disorder	2.57e-05	0.000176	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TCF7L2—bipolar disorder	2.56e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD2—bipolar disorder	2.54e-05	0.000174	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADCY2—bipolar disorder	2.52e-05	0.000172	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TCF7L2—bipolar disorder	2.51e-05	0.000172	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD2—bipolar disorder	2.49e-05	0.00017	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2A—bipolar disorder	2.48e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—POMC—bipolar disorder	2.41e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—POMC—bipolar disorder	2.36e-05	0.000161	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—COMT—bipolar disorder	2.31e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NTRK1—bipolar disorder	2.3e-05	0.000157	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NTRK1—bipolar disorder	2.26e-05	0.000154	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	2.25e-05	0.000154	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GSK3B—bipolar disorder	2.24e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—S100B—bipolar disorder	2.24e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—POMC—bipolar disorder	2.23e-05	0.000152	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—INS—bipolar disorder	2.21e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TAC1—bipolar disorder	2.21e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—S100B—bipolar disorder	2.19e-05	0.00015	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD1—bipolar disorder	2.17e-05	0.000148	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	2.17e-05	0.000148	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	2.11e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD3—bipolar disorder	2.1e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	2.09e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD4—bipolar disorder	2.04e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	1.98e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NRG1—bipolar disorder	1.98e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NRG1—bipolar disorder	1.94e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	1.92e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	1.91e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD2—bipolar disorder	1.9e-05	0.00013	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—bipolar disorder	1.87e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—bipolar disorder	1.8e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—bipolar disorder	1.78e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—bipolar disorder	1.75e-05	0.000119	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	1.72e-05	0.000117	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—S100B—bipolar disorder	1.67e-05	0.000114	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—bipolar disorder	1.49e-05	0.000102	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—INS—bipolar disorder	1.49e-05	0.000102	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NRG1—bipolar disorder	1.47e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GSK3B—bipolar disorder	1.43e-05	9.81e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—bipolar disorder	1.42e-05	9.73e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—INS—bipolar disorder	1.42e-05	9.68e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GSK3B—bipolar disorder	1.4e-05	9.6e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—bipolar disorder	1.39e-05	9.53e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—INS—bipolar disorder	1.39e-05	9.47e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	1.33e-05	9.09e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	1.07e-05	7.32e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—bipolar disorder	1.06e-05	7.26e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INS—bipolar disorder	1.06e-05	7.22e-05	CbGpPWpGaD
